News Sentiment

PHOE sentiment intelligence

Phoenix Asia Holdings Limited Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Industrials Market context
Industry Engineering & Construction Read-through group
Latest close 21.60 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+21.3% over one week, +35.0% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Negative

Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 21.3% Price confirming higher
Trend fit Trend inactive 35.0% over four weeks
Fair value 49.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 22
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
TradingKey 6
Moomoo 3
simplywall.st 3
Finviz 2
Sahm 2
Market source 2
www.marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 8
Deals and strategy 8
Analyst action 2
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
Finviz Direct company coverage

PHOE - Phoenix Asia Holdings Ltd Latest SEC Filings

This article provides the latest SEC filings and extensive financial data for Phoenix Asia Holdings Ltd (PHOE). It details various financial metrics including market cap, enterprise value, income, sales, P/E ratio, and insider ownership, alongside stock performance indicators and

Tone
Negative 41/100
Event
Market update
Published
25 Jun 2026 17:10
Source
Finviz
TradingKey Direct company coverage

Phoenix Asia Holdings Ltd (PHOE) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Phoenix Asia Holdings Ltd (PHOE), noting that key valuation metrics such as P/E, P/B, P/S, and P/CF have not yet been disclosed by the company. It briefly shows the stock's current market price, daily change, market cap, and TTM P/E

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Phoenix Asia Holdings Ltd (PHOE) Institutional Confidence

This article provides details on the institutional confidence score for Phoenix Asia Holdings Ltd (PHOE), including its current stock price, market capitalization, and P/E ratio. It lists key institutional shareholders and their recent activity, highlighting changes in shareholdi

Tone
Negative 34/100
Event
Market update
Published
18 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Phoenix Asia Holdings Ltd (PHOE) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Phoenix Asia Holdings Ltd (PHOE), including its current stock price, market capitalization, and P/E ratio. It highlights that no data for EPS, Revenue, EBIT, or Net Profit forecasts have been disclosed by the company yet. The page se

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

Phoenix Asia Holdings Ltd (PHOE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Phoenix Asia Holdings Ltd (PHOE), detailing its current stock price, market capitalization, and various technical indicators. It presents a summary of MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX, and MA, along with their values and d

Tone
Negative 40/100
Event
Market update
Published
18 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

Phoenix Asia Holdings Ltd (PHOE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides an overview of Phoenix Asia Holdings Ltd (PHOE), including its real-time stock quotes, market capitalization, and P/E ratio. The primary focus of the article, which is revenue breakdown by business segment and region, states that the relevant

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 23:40
Source
TradingKey
Finviz Direct company coverage

PHOE - Phoenix Asia Holdings Ltd Stock Price and Quote

This article provides detailed stock information for Phoenix Asia Holdings Ltd (PHOE), including its latest closing price, percentage change, and key financial metrics. It also lists recent news and corporate announcements, such as earnings calls, board appointments, and IPO deta

Tone
Negative 19/100
Event
Earnings
Published
09 Jun 2026 07:41
Source
Finviz
TradingKey Direct company coverage

TradingKey

This page from TradingKey provides a stock quote and basic company information for Phoenix Asia Holdings Ltd (PHOE). The stock closed at $20.340, down 15.46% on May 11th, with a market cap of $519.70M and a P/E TTM of 738.29. The page primarily serves as a placeholder for stock-r

Tone
Negative 32/100
Event
Market update
Published
12 May 2026 01:09
Source
TradingKey
Sahm Direct company coverage

Phoenix Asia Holdings (PHOE) Stock Surges Over 47% After Hours: Here's Why

Phoenix Asia Holdings (PHOE) shares surged over 47% in after-hours trading following the announcement of a $1 billion stock acquisition agreement to purchase clinical-stage pharmaceutical firm ACEA Pharma Inc. This deal marks a significant shift for Phoenix Asia Holdings from its

Tone
Positive 76/100
Event
Deals and strategy
Published
08 May 2026 23:39
Source
Sahm
Simply Wall Street Direct company coverage

Assessing Phoenix Asia Holdings (NasdaqCM:PHOE) Valuation After Sharp Short Term Share Price Swings

Phoenix Asia Holdings (PHOE) has experienced significant share price volatility, with a recent 39.14% decline contrasting sharply with longer-term gains. The company, focused on substructure construction in Hong Kong, currently trades at a price-to-book (P/B) ratio of 82.4x, whic

Tone
Negative 36/100
Event
Market update
Published
08 May 2026 18:38
Source
Simply Wall Street
The Manila Times Direct company coverage

Phoenix Asia Holdings Limited Announces Entering into Stock Acquisition Agreement and Convertible Promissory Note

Phoenix Asia Holdings Limited has announced an agreement to acquire 100% of ACEA Pharma, Inc., a clinical-stage pharmaceutical company, in exchange for 100 million of Phoenix Asia's ordinary shares. This acquisition signifies Phoenix Asia's strategic shift from substructure works

Tone
Positive 73/100
Event
Deals and strategy
Published
08 May 2026 11:12
Source
The Manila Times
Market source Direct company coverage

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited

Scilex Holding Company announced that its subsidiaries, ACEA Therapeutics and ACEA Pharma, have entered into a definitive agreement with Phoenix Asia Holdings Limited. Under this agreement, Phoenix will acquire 100% of ACEA Pharma's equity in exchange for 100 million newly-issued

Tone
Neutral 50/100
Event
Market update
Published
06 May 2026 05:40
Source
Market source
Quiver Quantitative Direct company coverage

Scilex Holding Company Announces Acquisition Agreement Between ACEA Therapeutics and Phoenix Asia Holdings

Scilex Holding Company announced that its subsidiary ACEA Therapeutics will transfer and sell its wholly-owned subsidiary ACEA Pharma to Phoenix Asia Holdings Limited for $1 billion in newly-issued shares. Post-acquisition, Phoenix will be renamed ACEA Pharma, Inc. and is expecte

Tone
Neutral 50/100
Event
Deals and strategy
Published
05 May 2026 17:10
Source
Quiver Quantitative
Moomoo Direct company coverage

Phoenix Asia Holdings: Target Co Is Clinical Stage Pharmaceutical Co With Diverse Pdt Portfolio to Address Unmet Medical Needs in Cancer, Autoimmune Disease, Covid-19 >PHOE

Phoenix Asia Holdings announced that its target company is a clinical-stage pharmaceutical company. This company focuses on developing a diverse product portfolio to address unmet medical needs in significant disease areas including cancer, autoimmune diseases, and Covid-19.

Tone
Positive 66/100
Event
Analyst action
Published
05 May 2026 06:10
Source
Moomoo
Stock Titan Direct company coverage

Phoenix Asia (NASDAQ: PHOE) pivots to pharma with $1B ACEA acquisition

Phoenix Asia Holdings Limited (NASDAQ: PHOE) announced a significant pivot from its Hong Kong-based substructure works business to the pharmaceutical industry through the acquisition of ACEA Pharma, Inc. for $1 billion in newly issued equity. The deal involves issuing 100,000,000

Tone
Negative 34/100
Event
Deals and strategy
Published
05 May 2026 04:09
Source
Stock Titan
TipRanks Direct company coverage

Phoenix Asia to Acquire ACEA Pharma in $1 Billion All-Stock Deal and Pivot into Pharmaceuticals

Phoenix Asia Holdings Ltd. (PHOE) is set to acquire ACEA Pharma, Inc. in a $1 billion all-stock deal involving 100 million new shares, marking a significant strategic pivot from construction to pharmaceuticals. The acquisition, expected to close in Q2 2026, will transform Phoenix

Tone
Neutral 50/100
Event
Deals and strategy
Published
04 May 2026 21:09
Source
TipRanks
Stock Titan Direct company coverage

Hong Kong builder strikes drug-company deal, adds $20M note

Phoenix Asia Holdings Limited (PHOE), a Hong Kong-based substructure works company, has announced a significant shift in its business by entering into a Stock Acquisition Agreement to purchase 100% of ACEA Pharma, a clinical-stage pharmaceutical company. This acquisition will exp

Tone
Neutral 50/100
Event
Deals and strategy
Published
04 May 2026 20:09
Source
Stock Titan
www.marketscreener.com Direct company coverage

ACEA Pharma, Inc. agreed to acquire Phoenix Asia Holdings Limited from Phoenix Prosperity Investment Limited and others in a reverse merger transaction for $1.0 billion.

ACEA Pharma, Inc. has agreed to acquire Phoenix Asia Holdings Limited in a reverse merger transaction valued at $1.0 billion. The acquisition involves ACEA Pharma issuing 100 million common equity shares, worth $1 billion, for the common equity of Phoenix Asia Holdings Limited. T

Tone
Positive 72/100
Event
Deals and strategy
Published
04 May 2026 17:39
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Phoenix Asia Holdings Limited announced that it has received $20 million in funding from Phoenix Prosperity Investment Limited

Phoenix Asia Holdings Limited has secured $20 million in funding from Phoenix Prosperity Investment Limited through the issuance of convertible promissory notes. The notes, maturing in three years, do not accrue interest and are convertible into ordinary shares at $10 per share.

Tone
Positive 70/100
Event
Market update
Published
04 May 2026 05:09
Source
www.marketscreener.com
Seeking Alpha Direct company coverage

Phoenix Asia Holdings: Infra Spending May Lift But No Value Angle

Phoenix Asia Holdings (PHOE) is a Hong Kong-focused subcontractor whose revenue is highly concentrated and exposed to the region's public infrastructure spending. Despite potential recovery in residential property and incoming infrastructure funding, the company's backlog has sha

Tone
Negative 30/100
Event
Earnings
Published
03 May 2026 04:39
Source
Seeking Alpha
Quantisnow Direct company coverage

Phoenix Financial Joins MSCI World Index

Phoenix Financial (PHOE) has been added to the MSCI World Index. This announcement was delivered via Quantisnow, a market data and news platform that aggregates financial information for investors. Quantisnow provides real-time updates on SEC filings, FDA approvals, analyst ratin

Tone
Positive 72/100
Event
Analyst action
Published
01 May 2026 11:39
Source
Quantisnow